« Previous
Next »
Titles
- Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate1
- Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees1
- Generic drugs: your Rx for savings1
- Getting to the root of high prescription drug prices: drivers and potential solutions1